Literature DB >> 10675406

The effects of interferon on the expression of human papillomavirus oncogenes.

K Y Kim1, L Blatt, M W Taylor.   

Abstract

The effects of interferon (IFN)-alpha, IFN-beta and IFN-gamma on human papillomavirus (HPV) oncogene expression were studied in various cervical carcinoma cell lines containing integrated copies of either HPV type 16 or HPV type 18. The levels of E6 and E7 transcripts were examined 6 h and 30 h after treatment with IFN. In HeLa cells, all three classes of IFNs effected a decrease in the level of HPV-18 E6 and E7 transcripts. On the other hand, none of the IFNs altered the level of these transcripts in C-4II cells. Only IFN-gamma decreased the level of HPV-16 E6 and E7 transcripts in CaSki and HPK1A cells, while IFN-gamma actually increased the level of these transcripts in SiHa cells. This differential IFN regulation of HPV expression in various cervical cancer cell lines may account for the contradictory clinical results observed after treatment of cervical cancer with IFN.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10675406     DOI: 10.1099/0022-1317-81-3-695

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  10 in total

Review 1.  The Interaction Between Human Papillomaviruses and the Stromal Microenvironment.

Authors:  B Woodby; M Scott; J Bodily
Journal:  Prog Mol Biol Transl Sci       Date:  2016-10-11       Impact factor: 3.622

Review 2.  hrHPV E5 oncoprotein: immune evasion and related immunotherapies.

Authors:  Antonio Carlos de Freitas; Talita Helena Araújo de Oliveira; Marconi Rego Barros; Aldo Venuti
Journal:  J Exp Clin Cancer Res       Date:  2017-05-25

3.  Human papillomavirus type 16 E5 protein induces expression of beta interferon through interferon regulatory factor 1 in human keratinocytes.

Authors:  Valentina Muto; Emilia Stellacci; Angelo Giuseppe Lamberti; Edvige Perrotti; Aurora Carrabba; Giovanni Matera; Marco Sgarbanti; Angela Battistini; Maria Carla Liberto; Alfredo Focà
Journal:  J Virol       Date:  2011-03-09       Impact factor: 5.103

4.  Complexes of human papillomavirus type 16 E6 proteins form pseudo-death-inducing signaling complex structures during tumor necrosis factor-mediated apoptosis.

Authors:  Maria Filippova; Valery A Filippov; Mercy Kagoda; Theodore Garnett; Nadya Fodor; Penelope J Duerksen-Hughes
Journal:  J Virol       Date:  2008-10-08       Impact factor: 5.103

Review 5.  Human papillomavirus and cervical cancer.

Authors:  Eileen M Burd
Journal:  Clin Microbiol Rev       Date:  2003-01       Impact factor: 26.132

6.  Leukemia inhibitory factor downregulates human papillomavirus-16 oncogene expression and inhibits the proliferation of cervical carcinoma cells.

Authors:  Joseph M Bay; Bruce K Patterson; Nelson N H Teng
Journal:  Infect Dis Obstet Gynecol       Date:  2011-06-04

7.  Interferon-Tau has Antiproliferative effects, Represses the Expression of E6 and E7 Oncogenes, Induces Apoptosis in Cell Lines Transformed with HPV16 and Inhibits Tumor Growth In Vivo.

Authors:  Herbey Oswaldo Padilla-Quirarte; Cesar Trejo-Moreno; Geny Fierros-Zarate; Jhoseline Carnalla Castañeda; Marie Palma-Irizarry; Eva Hernández-Márquez; Ana Isabel Burguete-Garcia; Oscar Peralta-Zaragoza; Vicente Madrid-Marina; Kirvis Torres-Poveda; Victor Hugo Bermúdez-Morales
Journal:  J Cancer       Date:  2016-11-05       Impact factor: 4.207

Review 8.  Biological and clinical basis for molecular studies of interferons.

Authors:  Katie R Pang; Jashin J Wu; David B Huang; Stephen K Tyring; Samuel Baron
Journal:  Methods Mol Med       Date:  2005

9.  Stat1 confers sensitivity to radiation in cervical cancer cells by controlling Parp1 levels: a new perspective for Parp1 inhibition.

Authors:  Giuseppina Raspaglio; Marianna Buttarelli; Flavia Filippetti; Alessandra Battaglia; Alexia Buzzonetti; Giovanni Scambia; Daniela Gallo
Journal:  Cell Death Dis       Date:  2021-10-12       Impact factor: 8.469

10.  Interferon-beta treatment increases human papillomavirus early gene transcription and viral plasmid genome replication by activating interferon regulatory factor (IRF)-1.

Authors:  Michael J Lace; James R Anson; Aloysius J Klingelhutz; Hisashi Harada; Tadatsugu Taniguchi; Aaron D Bossler; Thomas H Haugen; Lubomir P Turek
Journal:  Carcinogenesis       Date:  2009-06-18       Impact factor: 4.944

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.